INSIGHTS ON CLINICAL TRIAL DESIGN
-
![GettyImages-1322828635 in home visit nurse]( "How Home Trial Visits Support Sites And Patients")
How Home Trial Visits Support Sites And PatientsBy reaching into the heart of communities, Home Trial Support plays an invaluable role in driving the development of lifesaving, representative, medicines and therapies.
-
![How Should Biosimilar Companies Approach Real-World Evidence?]( "Evidence Generation Evolved")
Evidence Generation EvolvedExplore how innovative strategies are cutting clinical trial times in half and accelerating the delivery of life-saving treatments.
-
![GettyImages-1731147638 research, cell culture]( "Gene, Cell, And RNA Therapy Landscape Continues To Thrive")
Gene, Cell, And RNA Therapy Landscape Continues To ThriveThe horizons of molecular medicine continued to expand in the Q4 2024, with pre-registration gene therapy programs up 83% from the third quarter.
-
![Problem solving challenge achievement GettyImages-1271935835]( "Helping Biotechs Overcome 4 Key Challenges")
Helping Biotechs Overcome 4 Key ChallengesDelays in site payments, participant reimbursements, and logistical inefficiencies can create roadblocks for patients and sites.
-
Smarter, More Accurate Patient Matching Enhances Trial Efficiency5/20/2025
Even when patient recruitment criteria grows complex, this direct-to-data approach can pinpoint precise patients needed and provide an alert to your team when they are found.
-
Combination Therapy Dose Optimization In Oncology Trials3/30/2026
Optimize dose selection in oncology trials by moving beyond toxicity limits. Use advanced modeling and benefit-risk analysis to improve efficacy and meet modern regulatory standards.
-
Practical Strategies For Diverse Trial Recruitment11/11/2024
The clock is ticking on the requirement for pharmaceutical companies to include FDA-mandated diversity action plans for pivotal studies in clinical trials.
-
Advancing Immunotherapy In Head And Neck Cancer: The IT-MATTERS Study4/17/2025
This randomized controlled pivotal Phase 3 study evaluated efficacy and safety of neoadjuvant complex biologic administered for three consecutive weeks pre-surgery.
-
Improving Rare Disease Recruitment With Data And AI4/15/2026
Finding patients for rare disease clinical trials can be an uphill battle; fortunately, there are ways sponsors can address the most common stumbling blocks in the recruitment process.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-956015576 knee altasciences_edited]( "Selecting The Right Pain Model For Early Phase Analgesic Trials")
Altasciences’ pain experts and neuroscientists are here to guide you in selecting the most appropriate pain model to successfully evaluate the efficacy and safety profile of your study drug.
-
![Global networking healthcare-GettyImages-1477437266]( "Engaging, Empowering & Supporting Research Sites Around The World")
Accelerate trial timelines and recruitment while reducing site burden through this site network solution.
-
![GettyImages-1695276785 lab, vial, research]( "Central Laboratory Services For Multi-Site Studies")
At DVCR, our Central Laboratory Services are built for multi-site studies, combining customizable kits, next-day results and real-time shipment monitoring to keep every site aligned and on schedule. Backed by dedicated client teams, a comprehensive Central Lab Manual and rapid-response testing, we deliver the flexibility and speed your studies require.
-
![GettyImages-1325251634-doctor-patient-blood-pressure-visit]( "Recruitment Strategies: A Behind The Scenes Look")
Explore a dynamic recruitment strategy being used to address the growing demand for participants in early-stage clinical trials while overcoming regulatory and ethical challenges.
-
![GettyImages-576902490 meeting presentation]( "Biotech-Tailored Clinical Development")
Strategic planning, data-driven decisions, and global coordination accelerate clinical timelines while ensuring quality. Explore risk-based monitoring and practical ways to overcome complexity.
